May 7, 2019 For Medical Cannabis Users, the Biggest Problem Is a Consistent Dose, Says Syqe Medical CEO View Article
April 11, 2019 Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Management of Medical Devices View Article
March 26, 2019 Cancer Biotech Firm Alpha Tau Medical Appoints Raphi Levy of Goldman Sachs as Chief Financial Officer View Article
March 7, 2019 Foamix Announces FDA Acceptance of New Drug Application for FMX101 Minocycline Foam for the Treatment of Moderate-to-Severe Acne View Article
February 27, 2019 Foamix Announces Positive Results from Phase 3 Open-Label Safety Study Evaluating FMX103 Topical Minocycline Foam for Treatment up to 1 Year View Article
February 23, 2019 Gamida Cell Announces Immune Reconstitution Data from Completed Phase 1/2 Clinical Study of NiCord® Presented at 2019 TCT Annual Meeting View Article
February 14, 2019 Anchiano Therapeutics Announces Pricing of $30.5 Million Initial Public Offering View Article
